Wound Care Markets, 4th. Edition, Vol. I: Skin Ulcers – Aarkstore Enterprise

Wound care is a constantly changing market. The trend toward cost-effective skin ulcer treatment remains embedded in management programs that emphasize prevention and early intervention. New wound care products and devices are entering the market with lightening speed, all striving for the best clinical outcomes. Kalorama’s Wound Care Markets, 4th Edition, Vol. I: Skin Ulcers. represents the fourth time that Kalorama has rexamined this aspect of the wound care market, and the study analyzes the market using the following product segments and subsegments:

• Anti-Infectives
  • Systemic
  • Topical
• Skin Ulcer Management
  • Compression Dressings and Bandages
  • Wound Cleaners
  • Debridement
• Moist Dressings
  • Alginates
  • Films
  • Foams
  • Hydrocolloids
  • Hydrogels
• Negative Pressure Wound Therapy
• Biological Dressings
  • Artificial Skin
  • Collagen
  • Growth Factors
  • Others
• Pressure Relief
• Miscellaneous Treatments

For each segment and subsegment, the report gives current market size and forecasted revenues years 2009 through 2013. Competitive market share information is provided by leading manufacturer for each major segment in the year 2006. Historical data are provided for each of the years 2003 through 2008. The study also details research developments, industry trends, and relevant epidemiologic and demographic data.

Since the last edition of Kalorama Information’s Wound Care Markets Series, there have been shifts in the market for treatment of skin ulcers. Up-to-date information was obtained from coverage of the world-renown Symposium on Advanced Wound Care and the Wound Healing Society convention. Background information was obtained from a comprehensive search of published literature and reports obtained from various government, business, medical trade, and international journals and company reports and releases. Key information from published literature was used to conduct interviews with over 62 industry executives and product managers to validate and obtain expert opinion on current and future trends in the wound care industry. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as in formulating market projections.

All market data pertain to the market at the manufacturers’ level. Data are expressed in current U.S. dollars.

Marketing directors, product managers, business development executives in the wound care industry, investment specialists considering investments in this area and consultants and advertising agencies who service wound care clients are among those who will find this study a useful resource.

License Note: Kalorama Information’s listed default price on its information products reflects a single user license only. Purchasing a departmental or global site license (for entire company) permits multiple individuals in the company to benefit from this resource.

http://www.aarkstore.com/reports/Wound-Care-Markets-4th-Edition-Vol-I-Skin-Ulcers-13480.html

IT Strategy and Architecture: Creating an Enterprise Model to Support IT Strategic Planning

The IT strategy of many organisations has evolved over a period of time rather than been purposely defined, and in many cases is not actually documented. However, businesses and customers expect IT systems and services to meet the requirements of the organisation with the consequent need for translating the organisation’s objectives into IT strategy and capabilities, in order that together they can respond to the rapidly-changing environment. The adoption of an end-to-end architectural approach can help with IT strategy planning and execution.

KEY FINDINGS
There needs to be a clear understanding of the enterprise goals and the role that the business expects IT to play.
To remain competitive, organisations must urgently address the growing dislocation between strategy and IT deliverables.
Defining an IT strategy is of little value if organisations are unable to measure the effectiveness of that strategy in delivering value.
Enterprise Architecture must take a leadership role in IT strategy and service delivery.
Special attention should be paid to the people and process aspects of Enterprise Architecture.
An enterprise model needs to be communicated in each stakeholder’s ‘language’, as well as being relevant to senior management and solution architects.
Architecture can benefit from a metrics-based and performance analytics-driven approach.
For architecture to become a respected discipline there needs to be additional encouragement.
Organisations should take a portfolio-based approach to selecting IT investments.

CATALYST
IT organisations are under pressure to develop an effective strategy and to deliver services that can support changing requirements. An architectural approach can offer a useful framework within which organisations can plan and execute IT strategy.

ANALYSIS

Introduction

The IT strategy of many organisations has evolved over a period of time rather than been purposely defined, and in many cases is not actually documented. However, businesses and customers expect IT systems and services to meet the requirements of the organisation with the consequent need for translating the organisation’s objectives into IT strategy and capabilities, in order that together they can respond to the rapidly-changing environment. The adoption of an end-to-end architectural approach can help with IT strategy planning and execution.

In order to improve competitiveness, organisations must urgently address the growing dislocation between the business requirements and IT deliverables. This issue is directly impacting the enterprise’s ability to make quick, accurate decisions and is causing slow implementation of the IT strategy. The gap between IT capability and business needs cannot be allowed to continue. Additionally, many organisations are struggling to highlight the value that IT is delivering to the businesses. Enterprise Architecture provides a useful framework within which organisations can address governance requirements by better planning and the ability to prove compliance, as well as providing an improved understanding of the value of technology investments.

Business Issues

Many IT strategies are assessed and updated yearly as part of the budgeting process and Enterprise Architecture initiatives are developed as isolated, ‘ivory-tower’ endeavours. A better method is to adopt an iterative process, and to use the opportunity to begin to translate IT strategy into reusable deliverables through architecture. This involves the adoption of an architectural approach, rather than the use of tactical undertakings where there is a possibility of reverting back to a siloed mentality, as there is no mechanism in place to interpret strategy and control delivery through the use of architecture, policies, patterns, and common standards.

The IT strategy must address the capabilities required to design and deploy IT solutions, and the way in which the organisation will exploit these capabilities to create business value, both of which must be measured to gauge their success. The IT capabilities include technology infrastructure, business applications, IT processes and services, and skills, which enable a portfolio of IT-enabled business projects and programmes. A balanced scorecard approach provides a unified view of IT strategy performance across all of these dimensions.

Enterprise Architecture is an important company asset that has to be managed and updated on an ongoing basis to ensure relevance is maintained. To successfully adopt Enterprise Architecture there has to be complete buy-in across the entire organisation, with an understanding of the allocation of the roles and responsibilities. Technology and business areas within the enterprise must work together to ensure that the architecture keeps in line with the strategic objectives of the company and adequately reflects the IT services available now and planned for the future.

Attempts to align IT strategy with an abstract business vision or strategy are doomed to failure, and within the Enterprise Architecture domain, an enterprise model is a way to deconstruct business strategy and objectives into something that is more tangible, and into which the other elements of the business environment can be integrated. Butler Group recommends an incremental approach based on continuous improvement when developing an enterprise model, focused at meeting the business objectives and where value can be delivered quickly. This can be achieved by the model only depicting just enough architecture to enable decisions to be made and by growing the model iteratively over time.

The belief is that Enterprise Architecture and engaging with senior management to define a top-level business architecture and enterprise model has become a necessity for any organisation wishing to effectively interpret IT strategy, and successfully utilise technology as an enabler for business agility and change.

http://www.aarkstore.com/reports/IT-Strategy-and-Architecture-Creating-an-Enterprise-Model-to-Support-IT-Strategic-Planning-13948.html

Global MEMS Technology Market in Healthcare Industry 2008-2012

With the increase in population, demand for healthcare products and services has also risen. Therefore, the healthcare industry is adopting new technologies such as Micro-Electro-Mechanical-Systems (MEMS) to counter the increasing complexities it has been facing and to en-cash the advantage of micromechanics. Medical devices based on MEMS technology could be very helpful for treating critical diseases and surgeries such as heart diseases, deficiencies in DNA sequencing, and linking gene deficiencies to disease. MEMS devices would be very helpful to counter threat from new diseases. Commercialization of ultra-compact diagnosis devices, with less stress to human body for diseases prevention and early stage diagnosis, is primarily driving the MEMS technology market in the healthcare industry. The aging world population, coupled with economic growth, urbanization, and change in lifestyles, is expected to increase the demand for modern MEMS based devices

The report by TechNavio Insights forecasts the size of the Global MEMS Technology Market in Healthcare Industry over the period 2008-2012. It segments the market into various geographic regions. The report also highlights the major applications of MEMS technology in the Healthcare Industry. Further, it discusses the key market trends, drivers and challenges of the Global MEMS Technology Market in Healthcare Industry and profiles some of the key vendors of this industry.

TechNavio Insights is a set of reports based on TechNavio – a market intelligence platform for the IT industry. It builds on the intelligence available within TechNavio, and leverages on the custom research experience of the ‘Technology Navigators’. TechNavio is built on years of experience of Infiniti Research in deep dive custom research and consulting for over 30 Fortune 500 companies and numerous large and mid-sized companies.

http://www.aarkstore.com/reports/Global-MEMS-Technology-Market-in-Healthcare-Industry-2008-2012-19503.html

Global Drug Infusion Pumps Market 2008-2012

Drug infusion pumps have a varied application in different environment and therapies. Due to this, a wide array of pumps are being manufactured and made available in the market. Thus, drug infusion pump manufacturers are realigning their marketing strategies and product delivery mechanism to appeal to the patients as well. With the abundant information available, patients have become more aware about healthcare issues, and can play an active role in the decision making process with their healthcare providers.

Developing countries hold potential growth prospects for drug infusion pumps market. The availability of cost effective and quality healthcare is driving the growth of medical tourism. Drug infusion pump manufacturers are focusing their strategies towards these emerging markets.
The report by TechNavio Insights forecasts the size of the Global Drug Infusion Pumps Market over the period 2008-2012. It segments the market into various geographic regions (representing the market size of each region). Further, it discusses the key market trends, driver and challenges of the Global Drug Infusion Pumps Market and profiles some of the key vendors of this market.

TechNavio Insights is a set of reports based on TechNavio – a market intelligence platform for the IT industry. It builds on the intelligence available within TechNavio, and leverages on the custom research experience of the ‘Technology Navigators’. TechNavio is built on years of experience of Infiniti Research in deep dive custom research and consulting for over 30 Fortune 500 companies and numerous large and mid-sized companies.

http://www.aarkstore.com/reports/Global-Drug-Infusion-Pumps-Market-2008-2012-19500.html

UK Consumer Insights 2009: Asda – Homewares – Aarkstore Enterprise

UK Consumer Insights 2009 are based around individual retailers and provide a highly detailed, data-rich overview of a retailer’s customers, drawing on a nationwide survey of 6,000 shoppers each year.

Reasons to Purchase

*New analysis, unique to these reports shows details about non-converting visitors including where they main shop and who they are.
*Analysis by non-standard demographics is also presented to give a comprehensive picture of a retailer’s customers.
*Key demographics include among others, sex, age, social class, television region, marital status, housing tenure, working status and ACORN group.
 
 
Table of Contents : 
“About the cDNA programme 3

Section 1: At a glance summary 4
- At a glance summary 5

Section 2: Share of shoppers 6
- Asda share of shoppers 7
- Asda share of shoppers by demographics 8
- Asda share of shoppers by television region 9
- Asda share of shoppers by household characteristics 10
- Asda share of shoppers by other characteristics and ACORN classification 11

Section 3: Conversion and non-conversion 12
- Asda conversion of visitors to main users 13
- Asda conversion of visitors to main users by demographics and region 14
- Asda conversion of visitors to main users by household characteristics 15
- Non-converting customers 16
- Profile of Asda non-converting customers by demographics and region 17

Section 4: Shopper profiles 18
- Asda profile of shoppers by demographics 19
- Asda profile of shoppers by television region 20
- Asda profile of shoppers by household characteristics 21
- Asda profile of shoppers by other characteristics and ACORN classification 22

Section 5: Loyalty 23
- Asda loyalty of main users 24
- Asda loyalty of main users by demographics and region 25
- Asda loyalty of main users by household characteristics 26
- Asda basic drivers of loyalty and disloyalty 27
- Asda detailed drivers of loyalty 28

Section 6: Competition 29
- Competition in homewares 30
- Cross sector competitor dynamics 31

For More Information Kindly Visit Below Link :
http://www.aarkstore.com/reports/UK-Consumer-Insights-2009-Asda-Homewares-15632.html

Pharmacogenomics for Clinical Use and in Drug Development – Aarkstore Enterprise

Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat specific segments of the population based on their particular responses to a drug. The knowledge of the likely effectiveness of a drug in a patient makes the drug more reliable, and fewer drugs would have to be taken off the market due to adverse reactions in some, but not all, of the patients to whom they were administered. Additionally, reducing the occurrence of adverse effects to a drug effectually reduces the cost of patient care overall. This Publications study examines the market for diagnostic tests based on this science and the clinical measurement methods, the reagents and supplies being utilized in clinical medicine and the pharmaceutical industry. This report presents an overview of the latest information regarding emerging new products and industry trends and will not only quantify, but also, qualify the pharmacogenomic market segments as an area of research, product development and investment opportunity. Forecasts of the pharmacogenomic market and an analysis of products in the worldwide diagnostics market will provide a basis for understanding the significance of past developments and the immense possibilities of the future.

For More Information, Kindly Visit :
http://www.aarkstore.com/reports/Pharmacogenomics-for-Clinical-Use-and-in-Drug-Development-13789.html

Medical Imaging Markets – Aarkstore Enterprise

There will be a steady increase in demand for medical imaging services, along with pressures to improve the quality of healthcare delivered in the home and to lower its cost. The medical imaging segments are poised for a major new phase of growth fueled by the availability of new technology coming out of the computer and digital information technology segment, and the higher interest of individual older baby boom patients and general healthcare consumers to monitor health status. Continuous improvements in technology are resulting in a growing number of new imaging tests that combine high levels of accuracy with rapid, easy-to-use product formats. Digital mammography is driving more screening programs. The purpose of this Publications report is to describe the specific market segment of the diagnostics market sector called medical imaging. This sector includes all of the generally-accepted imaging activities that are currently used today, including X-ray and radiography, mammography, magnetic resonance imaging (MRI), ultrasound, gamma camera market, computed tomography (CT) scans and positron emission tomography (PET) scans. It examines these clinical measurement devices and their reagents and supplies as used in hospitals, clinics and doctor’s offices. It also includes associated market segments like picture archiving and communications system (PACS) markets, cardiology imaging markets, three-dimensional (3D) imaging markets and other emerging technologies.

For More Information, Kindly Visit :
http://www.aarkstore.com/reports/Medical-Imaging-Markets-1325.html

Hematology Analyzer Instrumentation and Reagent Markets – Aarkstore Enterprise

Clinical hematology analyzer analysis is one of the oldest and most important sectors of clinical laboratory analysis. The hematology instrument and reagent market is centered around a group of instruments called hematology analyzers. The term clinical hematology analyzer usually refers to an automated instrument for determining the presence, number and type of cellular elements in easily collected body fluids, such as blood. However, it is not necessarily limited to these determinations. The hematology analysis always includes determination of non-cellular parameters in blood, such as hemoglobin and hematocrit. Other closely related areas of clinical interest are coagulation and flow cytometry. In fact, traditional specialization barriers, such as microbiology, hematology, blood banking, immunology and even anatomical pathology are rapidly fading both operationally and instrumentally. But for the sake of defining the subject to a reasonable size, the more traditional scope of clinical hematology analyzer will be the focus of this examination. The purpose of this Publications report is to describe the specific segments of the global clinical hematology analyzer instrumentation and reagent marketplace. The review covers those segments that are highly active in terms of innovation and growth. Specifically, this study examines the markets for small-lab, as well as highly-automated large-lab, platforms and accessory equipment, such as reagents, supplies and add-on equipment from original equipment manufacturers.
 
 
 
Table of Contents : 
1. Overview 7
1.1 Objectives of the Report 7
1.2 Methodology 8
1.3 Scope of the Report 8
1.4 Executive Summary 9

2 IVD Clinical Hematology Analyzer Market 11
2.1 Introduction 11
2.2 Key Product Segments 17
2.2.1 Hematology and Associates Instruments 17
2.2.1.1 Hematology Analyzers 17
2.2.1.2 Hematology Instruments Offerings by Major Players 17
2.2.1.2.1 Hematology Reagents and Controls 18
2.2.1.2.2 Hematology Point of Care Instruments 19
2.2.1.3 Flow Cytometers 20
2.2.1.3.1 Flow Cytometry Technology Platforms 20
2.2.1.3.2 Clinical Applications of Flow Cytometry 20
2.2.1.3.2.1 Leukocyte Analysis 20
2.2.1.3.2.2 Immunophenotyping of Leukemias and Lymphomas 21
2.2.1.3.2.3 Neutropenia 21
2.2.1.3.2.4 Platelet Analysis 21
2.2.1.3.2.5 T Cell Subsets 22
2.2.1.3.2.6 Reticulocyte Count 22
2.2.1.3.3 Flow Cytometry Market Growth 22
2.2.1.3.3.1 Applications 23
2.2.1.3.3.2 Market Size 23
2.2.1.3.3.3 Instrumentation Preferences 24
2.2.1.3.3.4 Reagent Selection and Use 24
2.2.1.3.3.5 Instrument Manufacturers 25
2.2.1.3.3.6 Future Directions of Flow Cytometry 26
2.2.1.4 Coagulation Analyzers 26
2.2.1.4.1 Coagulation Market Size 27
2.2.1.4.2 Prothrombin Time Test 28
2.2.1.4.3 Activated Partial Thromboplastin Time (APTT) 28
2.2.1.4.4 Clinical Advantages of Coagulation Testing 29
2.2.1.4.5 Coagulation Instruments 30
2.2.1.4.5.1 Roche Diagnostics 30
2.2.1.4.5.2 Avocet Medical 31
2.2.1.4.5.3 International Technidyne Corporation 31
2.2.1.4.5.4 Cardiovascular Diagnostics 32
2.2.1.4.5.5 Diagnostica Stago’s STA-R Evolution 32
2.2.1.4.5.6 Other Companies 33
2.2.1.4.5.7 Coagulation Reagents 34
2.2.1.5 Hemoglobinometers 34
2.2.1.6 Slide Stainers 34
2.2.1.7 Differential Counters 36
2.2.1.8 Hematology Stains 37
2.3 Blood Components 37
2.3.1 Complete Blood Count (CBC) 37
2.3.2 Red Blood Cells (RBCs) 38
2.3.3 White Blood Cells (WBCs) 38
2.3.4 Platelets 39
2.3.5 Hematocrit (HCT) 39
2.4 Hematology Tests 39
2.5 The Coulter Principle 40
2.6 Blood Collection 40
 
 For More Information, Kindly Visit :
http://www.aarkstore.com/reports/Hematology-Analyzer-Instrumentation-and-Reagent-Markets-1314.html

Global Beverages Report – Aarkstore Enetrprise

Until recently, the beverages market was divided simply between alcoholic and non-alcoholic beverages. As consumers’ tastes grew more sophisticated and demand surged for a variety of beverage options catering to lifestyle changes and health concerns, the beverages industry has responded with a dizzying array of options to choose from. This report focuses on the U.S. and world markets for beverages across several broad categories.

For the purposes of this study, This Publications has divided the global beverages markets into the following product segments include:
1) alcoholic beverages such as wines, beers and spirits
2) non-alcoholic beverages such as bottled water and milk
3) brewed beverages such as coffees and teas
4) carbonated beverages such as sodas and soft drinks
5) non-carbonated juice products both fresh and pre-packaged
6) energy drinks which are generally caffeinated beverages in both carbonated and non-carbonated forms. For each market segment, this study presents the latest information on size, growth rates, sales projections and factors influencing growth in the U.S. and internationally.
 
 
Table of Contents : 
1. Introduction 21
1.1 Objectives 21
1.2 Scope 21
1.3 Methodology 21
1.4 Executive Summary 22

2. Global Outlook 23
2.1 Soft Drinks 23
2.2 Bottled Water 24
2.3 Carbonates 24
2.4 Fruit Juices 25
2.5 Alcoholic 26
2.6 Brewed 30

3. Market for Beverages in Selected Countries 34
3.1 Beverage Market in the U.S. 34
3.1.1 U.S. Emerging Beverages 35
3.1.2 U.S. Kid’s Beverages 36
3.1.3 U.S. Organic Beverages Market 37
3.2 Beverage Market in Canada 38
3.3 Beverages Market in the E.U. 41
3.4 Beverages Market in France 42
3.5 Beverage Market in Italy 47
3.6 Beverage Market in China 47
3.7 Beverages Market in India 49
3.8 Beverages Market in Mexico 49
3.9 The Health-related Problems of Calories-rich Beverages 50

For More Information, Kindly Visit :
http://www.aarkstore.com/reports/Global-Beverages-Report-23112.html

Top 10 Medical Device Technology – Aarkstore Enterprise

Technological innovations in the medical device industry have led to a radical transformation in patient care. This report identifies the sectors with the industry’s most important developments related to patient care, clinical outcomes, and new product development. While the scope of the report is limited to the top ten technologies only, it covers almost the entire medical device market.

Scientific and medical technology breakthroughs – such as minimally invasive surgery (MIS) – have accelerated the accuracy of clinical outcomes and have also reduced recovery times and the medical costs borne by patients. This has led to radical transformation in patient care.

IT integration in medical imaging and medical devices has given a significant boost to the healthcare industry, a trend that is apparent in the market growth of drug eluting stents and telemedicine technologies. The markets covered in the report have a current potential of $454.3 billion and are expected to grow at a CAGR of 9.8% between 2009 and 2014.

Market estimates and forecast
The report provides in-depth market estimates and forecast for top ten medical device technologies as follows:
• Diagnostic imaging (nuclear imaging, interventional radiology, capsule endoscopy and others)
• Drug delivery (needle free injections, transdermal systems, inhalation system, infusion system)
• Molecular diagnostics (biosensors, proteomics, nanotechnology, and others)
• Mobility aid technologies
• Minimal/non-invasive surgery (stents, bariatric surgery, medical robotics and others)
• Micro-fluids and MEMS (Miniature medical pressure sensors, bio chips, protein chips)
• Non-invasive monitoring (continuous blood glucose monitoring)
• Biomaterials (bionic limbs, joint replacement, antimicrobial wound dressing and others)
• Bio-implants (neurostimulation and others)
• Tele-medicines

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide more than 100 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides 50 company profiles for each of its sub-segments.
What makes our reports unique?
• We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
• Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and minimum 50 micro markets, which are collectively exhaustive and mutually exclusive.
• No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, ROW.
• We provide 10% customization – Research shows that more than 40% of the times, clients do not get the specific intelligence they need in multi-client market research reports. We offer 10% customization in our reports at no extra cost. Get the exact market intelligence you require with real value for money.
• 15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
• Comprehensive market analysis for pharmaceutical and biotech companies, medical device manufacturers, pharma-research labs, doctors, physicians and hospitals, medical/pharma associations, retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered
• Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
• What are market estimates and forecasts; which markets are doing well and which are not?
• Where are the gaps and opportunities; what is driving the market?
• Which are the key playing fields? Which are the winning edge imperatives?
• How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and Analysis
The analysts working come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

For More Information, Kindly Visit :
http://www.aarkstore.com/reports/Top-10-Medical-Device-Technology-27527.html